Peers vs. pros: study tests if Patient-Led groups improve schizophrenia outcomes
NCT ID NCT03246932
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a peer-led psycho-education program (where trained patients lead group sessions) helps adults with schizophrenia improve symptoms and daily functioning over two years. 342 participants were randomly assigned to peer-led groups, professional-led groups, or usual care alone. The goal was to see if peer support offers lasting benefits beyond standard treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- peer-led psycho-education group sessions
- What this could lead to
- If effective, this approach could offer a low-cost, community-based way to help people with schizophrenia manage their condition better over the long term.
- What could go wrong
- The study is completed but results are not yet widely known; peer-led programs may not outperform professional-led ones, and benefits may be modest or inconsistent.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
342 people
The number who actually took part.
- Started
-
Dec 2020
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 64 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * patients, aged 18+, attending one psychiatric outpatient clinic under study; * diagnosed as schizophrenia and its subtypes according to the Diagnostic and Statistical Manual, 4th Text-Revised Edition, as ascertained by the Structured Clinical Interview (SCID-I); * having onset of the illness for not \>5 years; and * able to communicate in Cantonese language. Exclusion Criteria: * mentally unstable and unfit for study participation at recruitment; * with co-morbidity of other severe mental health problems such as depression and substance misuse; and * have recently received or are receiving any structured psychosocial intervention.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Schizophrenia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Jilin Medical College
Jilin City, Jilin, 0432, China
-
TM Psy Centre
Tuenmen, NT, Hong Kong
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Your voice may reveal if You're taking your psychiatric medication
- Scientists probe brain's reward system in mental illness
- New schizophrenia drug targets brain glutamate, not dopamine
- New drug candidate takes aim at schizophrenia symptoms
- New schizophrenia drug goes Head-to-Head with standard antipsychotics in Long-Term trial
- Five-Year safety check for experimental schizophrenia drug